Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CES1 | P23141 | 2/20 | 1.00 |
| ▸ | BCHE | P06276 | 1/20 | 1.00 |
| ▸ | MAOA | P21397 | 3/20 | 0.73 |
| ▸ | ALDH1A1 | P00352 | 7/20 | 0.55 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.55 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.55 |
| ▸ | MIF | P14174 | 3/20 | 0.52 |
| ▸ | MAOB | P27338 | 2/20 | 0.52 |
| ▸ | KDM4E | B2RXH2 | 5/20 | 0.50 |
| ▸ | HPGD | P15428 | 2/20 | 0.50 |
| ▸ | MEN1 | O00255 | 2/20 | 0.50 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.50 |
| ▸ | RNASEH1 | O60930 | 1/20 | 0.50 |
| ▸ | TDP2 | O95551 | 1/20 | 0.48 |
| ▸ | CASP3 | P42574 | 1/20 | 0.48 |
| ▸ | CASP7 | P55210 | 1/20 | 0.48 |
| ▸ | CASP9 | P55211 | 1/20 | 0.48 |
| ▸ | CASP6 | P55212 | 1/20 | 0.48 |
| ▸ | CASP8 | Q14790 | 1/20 | 0.48 |
| ▸ | MAP3K14 | Q99558 | 1/20 | 0.48 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL669542 | 1.00 | CES1 (1.00) | CES1BCHEMAOAALDH1A1CYP1A2 | |
| Ammonia Solution, Strong SCHEMBL27635852 | 0.98 | CES1 (0.95) | CES1BCHEMAOAALDH1A1CYP1A2 | |
| Charcoal, Activated SCHEMBL30220090 | 0.98 | CES1 (0.95) | CES1BCHEMAOAALDH1A1CYP1A2 | |
| SCHEMBL31068443 | 0.98 | CES1 (0.95) | CES1BCHEMAOAALDH1A1CYP1A2 | |
| SCHEMBL9146911 | 0.95 | CES1 (0.91) | CES1BCHEMAOAALDH1A1CYP1A2 | |
| Naphthalene SCHEMBL28976256 | 0.93 | CES1 (0.87) | CES1BCHEMAOAALDH1A1CYP1A2 | |
| SCHEMBL5809328 | 0.93 | CES1 (0.86) | CES1BCHEMAOAALDH1A1CYP1A2 | |
| SCHEMBL31746094 | 0.91 | CES1 (0.83) | CES1BCHEMAOAALDH1A1CYP1A2 | |
| Thiophene SCHEMBL18041171 | 0.88 | CES1 (0.77) | CES1BCHEMAOAALDH1A1CYP1A2 | |
| SCHEMBL989081 | 0.86 | CES1 (0.75) | CES1BCHEMAOAALDH1A1CYP1A2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 395 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260085232-A1 | ELECTROCHROMIC DEVICES USING NON-HALOGENATED ANIONS | POLYCEED INC. (US) | 2026-03-26 | — | — | US | claimed |
| EP-4665773-A1 | CYCLIC INITIATORS IN ADDITIVE MANUFACTURING | Align Technology, Inc. (US) | 2025-12-24 | — | — | EP | claimed |
| EP-4649314-A2 | POLYOL SWEETENERS AND CARDIOVASCULAR AND THROMBOTIC EVENT RISK | The Cleveland Clinic Foundation (US) | 2025-11-19 | — | — | EP | claimed |
| EP-4522026-A1 | FINGERMARK ENHANCEMENT APPARATUS | Foster & Freeman Limited (GB) | 2025-03-19 | — | — | EP | claimed |
| CN-119522228-A | Electron transport material, perovskite solar cell and electricity utilization device | 宁德时代新能源科技股份有限公司 | 2025-02-25 | — | — | CN | claimed |
| WO-2025033225-A1 | CURABLE COMPOSITION, FILM, OPTICAL FILTER, SOLID-STATE IMAGING ELEMENT, AND IMAGE DISPLAY DEVICE | 富士フイルム株式会社 | 2025-02-13 | — | — | WO | claimed |
| CN-115677580-B | Quaternary-carbon-containing indandione tetrahydroquinoline spiro alkaloid, preparation method thereof and application thereof in preparation of antitumor drugs | 中南民族大学 | 2025-02-07 | — | — | CN | claimed |
| CN-119306662-A | Method for constructing molten pyridine compound by copper-catalyzed [2+1+3] cyclization reaction of cyclic ketone with alpha, beta-unsaturated aldehyde/ketone and ammonium iodide | 湖南大学 | 2025-01-14 | — | — | CN | claimed |
| US-20240425704-A1 | CYCLIC INITIATORS IN ADDITIVE MANUFACTURING | ALIGN TECHNOLOGY, INC. | 2024-12-26 | — | — | US | claimed |
| EP-3571993-B1 | METHOD FOR DEVELOPING BIOLOGICAL TRACE EVIDENCE ON POROUS OBJECT | SUZHOU XIAOSONG SCIENCE & TECH DEVELOPMENT CO LTD (CN) | 2024-12-11 | — | — | EP | claimed |
| WO-2022171098-A1 | ARTIFICIAL SMALL MOLECULE INTERFERING PEPTIDE OF DAPK1 PHOSPHORYLATED SUBSTRATE AND PHARMACEUTICAL USE THEREOF | 北京欣安诚科技有限公司 | 2022-08-18 | — | — | WO | claimed |
| CN-107343806-B | Methods, devices, and systems for blood flow | 美多斯国际有限公司 | 2022-07-05 | — | — | CN | claimed |
| US-11352500-B2 | Squaraine-based molecules as material for organic photoelectric conversion layers in organic photodiodes | SONY CORPORATION (JP) | 2022-06-07 | — | — | US | claimed |
| US-20220160756-A1 | CARBON MONOXIDE-BASED THERAPIES AND IMPLANTABLE DEVICES FOR THE TREATMENT OF VASCULAR DISEASE | THE REGENTS OF THE UNIVERSITY OF MICHIGAN | 2022-05-26 | — | — | US | claimed |
| WO-2022098917-A1 | PHOTOACTIVE COMPOUNDS FOR VAPOR DEPOSITED ORGANIC PHOTOVOLTAIC DEVICES | UBIQUITOUS ENERGY, INC. (US) | 2022-05-12 | — | — | WO | claimed |
| US-20220149298-A1 | PHOTOACTIVE COMPOUNDS FOR VAPOR DEPOSITED ORGANIC PHOTOVOLTAIC DEVICES | UBIQUITOUS ENERGY, INC. (US) | 2022-05-12 | — | — | US | claimed |
| US-20220140266-A1 | PHOTOACTIVE COMPOUNDS FOR VAPOR DEPOSITED ORGANIC PHOTOVOLTAIC DEVICES | UBIQUITOUS ENERGY, INC. (US) | 2022-05-05 | — | — | US | claimed |
| US-20220135587-A1 | PHOTOACTIVE COMPOUNDS FOR VAPOR DEPOSITED ORGANIC PHOTOVOLTAIC DEVICES | UBIQUITOUS ENERGY, INC. (US) | 2022-05-05 | — | — | US | claimed |
| CN-114262272-A | Naphthalene-indene diketone donor-acceptor compound, preparation method thereof and application thereof in lipid drop wash-free fluorescent probe | 山东大学 | 2022-04-01 | — | — | CN | claimed |
| CN-109254149-B | Method for showing occult blood trace and special reagent thereof | 公安部物证鉴定中心 | 2022-02-25 | — | — | CN | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20220140266-A1 | PHOTOACTIVE COMPOUNDS FOR VAPOR DEPOSITED ORGANIC PHOTOVOLTAIC DEVICES | VIM, ALDH1A2, ICAM1 | CES1 4747/4885BCHE 2962/4885MAOA 2886/4885 |
| US-20260085232-A1 | ELECTROCHROMIC DEVICES USING NON-HALOGENATED ANIONS | KCNJ2, NDUFS3, NDUFS4 | CES1 4659/4885BCHE 3462/4885MAOA 704/4885 |
| US-20220160756-A1 | CARBON MONOXIDE-BASED THERAPIES AND IMPLANTABLE DEVICES FOR THE TREATMENT OF VASCULAR DISEASE | MB, VCAM1, NOS2 | CES1 2529/4885BCHE 1210/4885MAOA 1162/4885 |
| US-20220149298-A1 | PHOTOACTIVE COMPOUNDS FOR VAPOR DEPOSITED ORGANIC PHOTOVOLTAIC DEVICES | VIM, ALDH1A2, ICAM1 | CES1 4747/4885BCHE 2962/4885MAOA 2886/4885 |
| US-20220135587-A1 | PHOTOACTIVE COMPOUNDS FOR VAPOR DEPOSITED ORGANIC PHOTOVOLTAIC DEVICES | VIM, ALDH1A2, ICAM1 | CES1 4747/4885BCHE 2962/4885MAOA 2886/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.